Baseline Characteristics in the VERIFY Study: A Randomized Trial Assessing the Durability of Glycaemic Control With Early Vildagliptin-Metformin Combination in Newly Diagnosed Type 2 Diabetes

Diabetic Medicine - United Kingdom
doi 10.1111/dme.13886